Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. BIOREM Inc.
  6. News
  7. Summary
    BRM   CA09068G1046

BIOREM INC.

(BRM)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

BIOREM Reports Third Quarter 2021 Financial Results

11/25/2021 | 07:45am EST

GUELPH, ON, Nov. 25, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2021. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

FINANCIAL HIGHLIGHTS:

 in Canadian dollars, '000's except earnings per share





Three-months ended

Nine -months ended


September 30

September 30


2021

2020

2021

2020






Revenue

4,576

3,586

13,639

16,441

Gross profit

1,137

629

2,531

3,364

Operating  expenses

1,282

418

2,860

2,070

Ebitda*

(71)

167

(84)

1,382

Net earnings (loss)

(115)

155

(287)

949

EPS - basic

(0.003)

0.004

(0.007)

0.025

EPS - fully diluted

(0.003)

0.004

(0.007)

0.025

* Earnings before interest, taxes and amortizaton, a non IFRS financial measure



Biorem's revenues for the third quarter were $4.6 million a 19% decrease over the previous quarter but $990,000 or 28% above the revenues reported in the same quarter in 2020.  Year to date revenues totalled $13.6 million, a 17% decrease over the $16.4 million reported for the first nine months of 2020. The decrease in revenues for the first nine months of 2021 compared to the prior year is due to some large project delays in North America that are expected to be caught up in the fourth quarter of the year.

Gross profit for the quarter was $1.1 million or 24.8% of revenue compared to $629,000 of gross profit representing 17.5 % of revenue recorded during the third quarter of 2020. Total operating expenses (net of other income) for the quarter were $1.3 million against $418,000 in the same period the prior year. The increase in operating expenses compared to the same period in the prior was primarily due to the value of foreign exchange gains and losses recorded. In the third quarter of 2021 a $269,000 foreign exchange loss was recognized while in the third quarter of 2020 a $246,000 foreign exchange gain was recorded.  Ebitda for the quarter was $(71,000) compared to $167,000 of ebitda in the third quarter of 2020.

Net loss for the quarter was $115,000, with year to date loss of $287,000 compared to net earnings of $949,000 for the first months of 2020.

"Third quarter revenues and earnings were below expectations and were again impacted by external non Biorem project delays", said Derek S. Webb, President and CEO. "These project delays in the first nine months of the year have set up the fourth quarter of 2021 to likely be record breaking in terms of revenues and earnings."

"New orders have continued to be secured, with approximately $5.4 million being closed in the third quarter.  This results in the BIOREM order backlog being $30.0 million on September 30, 2021 which provides a strong foundation for revenue over the next twelve months."

Cash on hand at September 30, 2021 stood at $9.9 million a small decline from the $10.2 million on hand on June 30, 2021. Earnings from operating activities during the quarter generated $172,000 of cash and this was offset by $760,000 of cash used to fund increases in non-cash working capital particularly inventories and prepaid expenses.

On August 5, 2021 the Company announced an agreement to purchase for cancellation 23,434,121 common shares from TPFG Environment Investment Limited. All regulatory approvals have been received and financing secured. The transaction is expected to close on or about December 1, 2021.

About BIOREM Inc.

BIOREM is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 1,600 installed systems worldwide, BIOREM offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.

Cision
View original content:https://www.prnewswire.com/news-releases/biorem-reports-third-quarter-2021-financial-results-301432010.html

SOURCE Biorem Inc.

© Canada Newswire, source Canada Newswire English

All news about BIOREM INC.
12/02BIOREM Announces Closing of Transaction to Purchase Common Shares for Cancellation
PR
11/25Biorem Reports Q3 Net Loss of $115,000, Revenue of $4.6 Million
MT
11/25BIOREM Reports Third Quarter 2021 Financial Results
AQ
11/24BIOREM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
11/17BIOREM Announces Application of Biological Reactors For "Natural Organic Reduction" Fac..
MT
11/17BIOREM Announces the Novel Application of its Biological Reactors to a New Market Segme..
AQ
11/17BIOREM : Novel Application of BIOREM's Biological Reactors
PU
09/17BIOREM : Shareholders Approve Purchase for Cancellation of Common Shares Held by TPFG
PU
09/17BIOREM : Gets Shareholder Approval for Planned Repurchase of Shares from TPFG Environment ..
MT
09/17BIOREM : Shareholders Approve Purchase for Cancellation of Common Shares Held by TPFG Envi..
AQ
More news
Financials
Sales 2020 24,4 M 19,3 M 19,3 M
Net income 2020 2,09 M 1,65 M 1,65 M
Net cash 2020 8,04 M 6,36 M 6,36 M
P/E ratio 2020 10,8x
Yield 2020 -
Capitalization 12,7 M 10,0 M 10,0 M
EV / Sales 2019 0,44x
EV / Sales 2020 0,53x
Nbr of Employees -
Free-Float 38,8%
Chart BIOREM INC.
Duration : Period :
BIOREM Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Derek S. Webb President, Chief Executive Officer & Director
Douglas Newman Chief Financial Officer & Secretary
Zhao Qing Chairman
Mark Smit Director-Technical Services
Dan Costello Director-Operations
Sector and Competitors
1st jan.Capi. (M$)
BIOREM INC.50.00%10
DONALDSON COMPANY, INC.3.20%7 165
EVOQUA WATER TECHNOLOGIES CORP.76.43%5 736
GVS S.P.A.-29.25%2 236
FUJIAN LONGKING CO., LTD.-6.53%1 390
ORGANO CORPORATION21.53%734